SEC Form 4 · Updated Daily

MNOV

— MEDICINOVA, INC. Ownership

Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.

FinancialsOwnership

Current Reporting Owners

OwnerRoleShares OwnedAs OfLast Activity
Himawan JeffDirector11,703,7042006-01-09—
Tanabe Holding America Inc.10%+ Owner5,000,0002006-10-13D
3D Investment Partners Pte. Ltd.Reporting Owner4,862,0472026-09-25S
3D Opportunity Master FundReporting Owner4,862,0472026-09-25S
Okajima MasatsuneOfficer1,040,5302019-02-28M
Satomi Hajime10%+ Owner1,000,0002013-05-13—
IWAKI YUICHIDirector · Officer966,9332021-07-09M
Nakata KousukeDirector800,0002011-11-29—
Kissei Pharmaceutical Co., Ltd.10%+ Owner800,0002011-10-13—
Izumi TatsuoDirector600,9702013-12-12S
Matsuda KazukoDirector · Officer322,9962021-08-23M
OBrien GeoffreyOfficer48,3182021-05-19M
Shigeta HiroakiDirector45,0002012-05-10M
Kalafer Michael EOfficer31,7442009-07-28P
Kobayashi YutakaDirector25,0002017-05-15P
Ishizaka YoshioDirector10,0002017-08-21P
Morris ArleneDirector8,8002013-05-21M
O'Toole David DOfficer5,0002012-05-29P
COFFEE MICHAEL DENISOfficer4,0002011-03-29P
Johnson Kirk WilliamOfficer1,7002011-03-29P
Asako ShintaroDirector02005-07-18—
Nagao HidekiDirector02022-11-28S

Recent Filings

DateOwnerActivitySharesPriceOwned After
2026-09-253D Opportunity Master FundOpen-market sale640,000$2.704,862,047
2026-09-253D Investment Partners Pte. Ltd.Open-market sale640,000$2.704,862,047
2026-06-23BEAVER CAROLYNGrant / award (derivative)44,500$0.0044,500
2026-06-23Lemerond NicoleGrant / award (derivative)44,500$0.0044,500
2026-06-23Nagao HidekiGrant / award (derivative)44,500$0.0044,500
2026-01-16IWAKI YUICHIGrant / award (derivative)450,000$0.00450,000
2026-01-16Matsuda KazukoGrant / award (derivative)350,000$0.00350,000
2025-06-17BEAVER CAROLYNGrant / award (derivative)20,000$0.0020,000
2025-06-17Lemerond NicoleGrant / award (derivative)20,000$0.0020,000
2025-06-17Nagao HidekiGrant / award (derivative)20,000$0.0020,000
2025-02-12BEAVER CAROLYNGrant / award (derivative)24,500$0.0024,500
2025-02-12IWAKI YUICHIGrant / award (derivative)100,000$0.00100,000
2025-02-12Lemerond NicoleGrant / award (derivative)24,500$0.0024,500
2025-02-12Matsuda KazukoGrant / award (derivative)100,000$0.00100,000
2025-02-12Nagao HidekiGrant / award (derivative)24,500$0.0024,500
2025-01-07Matsuda KazukoGrant / award (derivative)300,000$0.00300,000
2025-01-07IWAKI YUICHIGrant / award (derivative)400,000$0.00400,000
2024-06-11BEAVER CAROLYNGrant / award (derivative)20,000$0.0020,000
2024-06-11Lemerond NicoleGrant / award (derivative)20,000$0.0020,000
2024-06-11Nagao HidekiGrant / award (derivative)20,000$0.0020,000
2024-01-09IWAKI YUICHIGrant / award (derivative)210,000$0.00210,000
2024-01-09Matsuda KazukoGrant / award (derivative)157,500$0.00157,500
2024-01-09OBrien GeoffreyGrant / award (derivative)84,000$0.0084,000
2023-08-04Lemerond NicoleGrant / award (derivative)18,333$0.0018,333
2023-06-13BEAVER CAROLYNGrant / award (derivative)20,000$0.0020,000
2023-06-13Nagao HidekiGrant / award (derivative)20,000$0.0020,000
2023-01-23Matsuda KazukoGrant / award (derivative)149,625$0.00149,625
2023-01-23OBrien GeoffreyGrant / award (derivative)76,950$0.0076,950
2023-01-23IWAKI YUICHIGrant / award (derivative)235,125$0.00235,125
2022-11-28Nagao HidekiOpen-market sale6,754$2.250
2022-11-22Nagao HidekiOpen-market sale218$2.136,754
2022-11-21Nagao HidekiOpen-market sale5,365$2.186,972
2022-11-17Nagao HidekiOpen-market sale309$2.1812,337
2022-06-16BEAVER CAROLYNGrant / award (derivative)20,000$0.0020,000
2022-06-16Nagao HidekiGrant / award (derivative)20,000$0.0020,000
2022-01-27IWAKI YUICHIGrant / award (derivative)302,500$0.00302,500
2022-01-27Matsuda KazukoGrant / award (derivative)192,500$0.00192,500
2022-01-27OBrien GeoffreyGrant / award (derivative)99,000$0.0099,000
2021-08-23Matsuda KazukoOption exercise (derivative)60,000$0.000
2021-08-23Matsuda KazukoOption exercise60,000$2.30322,996

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.